Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Synthetic double-stranded short interfering RNA oligonucleotide directed against proopiomelanocortin

EU orphan designation number: EU/3/10/798   
Active ingredient: Synthetic double-stranded short interfering RNA oligonucleotide directed against proopiomelanocortin
Indication: Treatment of adrenocorticotropin-dependent Cushing´s syndrome
Sponsor: The University of Sheffield
Firth Court, Western Bank, Sheffield S10 2TN, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
06/10/2010 Centralised Orphan - Designation EMA/OD/038/10 (2010)6943 of 01/10/2010
21/09/2012 Centralised Orphan - Transfer of orphan designation EMA/OD/038/10/T/01 (2012)6516 of 14/09/2012